Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone

Market Cap
₹ 90 Cr
P/E
21.62
Bearish
3
Neutral
6
Bullish
5
Bearish
20
Neutral
7
Bullish
19
Bearish
17
Neutral
1
Bullish
14
Board Meeting Outcome
1 day ago
Board Meeting for Preferential Allotment
Orchasp Ltd has scheduled a board meeting on 18/12/2025 to consider the preferential allotment of 2,68,75,000 equity shares to Ms. Rajeswari Pattapurathi at an issue price of Rs. 3.20 per share.
Preferential Allotment
3 days ago
In Principle Approval for Preferential Allotment
The company has received in-principle approval for the allotment of 2,68,75,000 equity shares on a preferential basis from BSE and NSE.
Corporate Action
4 days ago
Incorporation of New Wholly Owned Subsidiary in USA
The company has incorporated a new wholly owned subsidiary named Orchasp Inc in the USA to market its healthcare platform.
IT - Software
Computers - Software - Medium / Small
90 Cr
Low Risk
21.6
38.4
—
0.8
4.19
2.02
Sales CAGR
1Y
59.09%
3Y
-17.31%
5Y
-16.36%
10Y
5.08%
Profit CAGR
1Y
-1647.06%
3Y
—
5Y
—
10Y
—
ROE
TTM
3.79%
3Y
-2.96%
5Y
-1.77%
10Y
-8.10%
ROCE
TTM
4.04%
3Y
-2.37%
5Y
-1.12%
10Y
-7.23%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 2.26 L in last 5 Years